1. Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival
   Dai Zhang et al, 2021, Front. Oncol. CrossRef
2. Case Report of a Breast Mass with Three Types of Malignant Tumors—Squamous Cell Carcinoma, Invasive Ductal Carcinoma, and Breast Sarcoma
   Chao Li et al, 2021, OTT CrossRef
3. null
   Sminu Bose et al, 2021 CrossRef
4. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
   Nuria Gómez-Cebrián et al, 2021, Cancers CrossRef
5. Development of a Gene Risk Signature for Patients of Pancreatic Cancer
   Tao Liu et al, 2022, Journal of Healthcare Engineering CrossRef
6. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes
   Cheng Yan et al, 2022, Front. Oncol. CrossRef
7. null
   Elisabeth Wik et al, 2022 CrossRef
8. Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
   Ashley Schreier et al, 2023, Front. Oncol. CrossRef
9. Immature natural killer cells promote progression of triple-negative breast cancer
   Gatha Thacker et al, 2023, Sci. Transl. Med. CrossRef
10. Identification and panoramic analysis of drug response-related genes in triple negative breast cancer using as an example NVP-BEZ235
    Jia Feng et al, 2023, Sci Rep CrossRef
11. Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines
    Mariana Gallo et al, 2023, The FEBS Journal CrossRef